Barclays »

Eyepoint Pharmaceuticals shares owned by Barclays

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Barclays

Quarter filed Position value Share count Share price at filing
2024-12-31 $895k 120k 7.44
2024-09-30 $2.0M 245k 7.99
2024-06-30 $418k 48k 8.71
2024-03-31 $6.2M 300k 20.67
2023-12-31 $3.7M 160k 23.11
2023-09-30 $365k 46k 7.99
2023-06-30 $195k 23k 8.69
2023-03-31 $82k 28k 2.93
2022-12-31 $25k 7.0k 3.57
2022-09-30 $9.0k 1.1k 8.14
2022-06-30 $10k 1.3k 7.64
2022-03-31 $49k 4.0k 12.11